Michael A. Benneyworth, Ph. D.

Affiliations: 
Neuroscience University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Serotonin, glutamate, schizophrenia, addiction
Google:
"Michael Benneyworth"
Mean distance: 14.9 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Balu DT, Takagi S, Puhl MD, et al. (2014) D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain. Cellular and Molecular Neurobiology. 34: 419-35
Balu DT, Li Y, Puhl MD, et al. (2013) Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proceedings of the National Academy of Sciences of the United States of America. 110: E2400-9
Coyle JT, Basu A, Benneyworth M, et al. (2012) Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. Handbook of Experimental Pharmacology. 267-95
Benneyworth MA, Coyle JT. (2012) Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2496-504
Benneyworth MA, Li Y, Basu AC, et al. (2012) Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons. Cellular and Molecular Neurobiology. 32: 613-24
Benneyworth MA, Roseman AS, Basu AC, et al. (2011) Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers. Neuroscience Letters. 488: 267-71
Benneyworth MA, Basu AC, Coyle JT. (2011) Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function. Psychopharmacology. 213: 143-53
Coyle JT, Balu D, Benneyworth M, et al. (2010) Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues in Clinical Neuroscience. 12: 359-82
Basu AC, Tsai GE, Ma CL, et al. (2010) Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior (Molecular Psychiatry (2009) 14 (719-727) DOI: 10.1038/mp.2008.130) Molecular Psychiatry. 15: 1122
Basu AC, Tsai GE, Ma CL, et al. (2009) Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Molecular Psychiatry. 14: 719-27
See more...